{"entity":{"type":"insider","cik":"0001453140","url":"/insider/0001453140","json_url":"/insider/0001453140.json","name":"DE SILVA RAJIV","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":15,"n_filings":11,"first":"2009-03-03","last":"2022-11-22","span_basis":"filed_date"},"name_variants":[{"name":"DE SILVA RAJIV","source":"filing","n_filings":11,"first_seen":"2009-03-03","last_seen":"2022-11-22"}],"transactions":[{"id":6732047,"accession":"0001567619-22-020779","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-22-020779","line_url":"/filing/0001567619-22-020779#line-1","is_derivative":false,"issuer_cik":"0001409269","issuer_name":"Venus Concept Inc.","issuer_ticker":"VERO","issuer_name_source":null,"issuer_url":"/issuer/0001409269","owner_cik":"0001453140","owner_name":"DE SILVA RAJIV","owner_display_name":"DE SILVA RAJIV","owner_url":"/insider/0001453140","role":"Officer (Officer)","role_mark":"O","role_mark_label":"Officer (Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1250000.0,"shares_display":"1,250,000","price_per_share":0.2,"price_display":"0.20","price_state":"stated","total_value":250000.0,"total_display":"250,000.00","total_whole":"250,000","shares_owned_after":1250000.0,"shares_owned_after_display":"1,250,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-18","filed_date":"2022-11-22","scope":"insider"},{"id":3316829,"accession":"0001209191-16-106481","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-106481","line_url":"/filing/0001209191-16-106481#line-1","is_derivative":false,"issuer_cik":"0001453140","issuer_name":"Endo International plc","issuer_ticker":"ENDP","issuer_name_source":null,"issuer_url":"/issuer/0001453140","owner_cik":"0001453140","owner_name":"DE SILVA RAJIV","owner_display_name":"DE SILVA RAJIV","owner_url":"/insider/0001453140","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2250.0,"shares_display":"2,250","price_per_share":44.5,"price_display":"44.50","price_state":"stated","total_value":100125.0,"total_display":"100,125.00","total_whole":"100,125","shares_owned_after":250705.0,"shares_owned_after_display":"250,705","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-03-07","filed_date":"2016-03-07","scope":"insider"},{"id":8803686,"accession":"0001209191-15-079480","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-079480","line_url":"/filing/0001209191-15-079480#line-1","is_derivative":false,"issuer_cik":"0001453140","issuer_name":"Endo International plc","issuer_ticker":"ENDP","issuer_name_source":null,"issuer_url":"/issuer/0001453140","owner_cik":"0001453140","owner_name":"DE SILVA RAJIV","owner_display_name":"DE SILVA RAJIV","owner_url":"/insider/0001453140","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9006.0,"shares_display":"9,006","price_per_share":55.52,"price_display":"55.52","price_state":"stated","total_value":500013.12,"total_display":"500,013.12","total_whole":"500,013","shares_owned_after":181380.0,"shares_owned_after_display":"181,380","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-11-11","filed_date":"2015-11-12","scope":"insider"},{"id":2130144,"accession":"0000885590-12-000075","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000885590-12-000075","line_url":"/filing/0000885590-12-000075#line-2","is_derivative":false,"issuer_cik":"0000885590","issuer_name":"Valeant Pharmaceuticals International, Inc.","issuer_ticker":"VRX","issuer_name_source":null,"issuer_url":"/issuer/0000885590","owner_cik":"0001453140","owner_name":"DE SILVA RAJIV","owner_display_name":"DE SILVA RAJIV","owner_url":"/insider/0001453140","role":"Officer (Pres & COO, Specialty Pharm)","role_mark":"O","role_mark_label":"Officer (Pres & COO, Specialty Pharm)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Pres & COO, Specialty Pharm","security_title":"Common Stock, no par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":76344.0,"shares_display":"76,344","price_per_share":54.0406,"price_display":"54.04","price_state":"stated","total_value":4125675.5664,"total_display":"4,125,675.57","total_whole":"4,125,676","shares_owned_after":265217.0,"shares_owned_after_display":"265,217","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-11-08","filed_date":"2012-11-09","scope":"insider"},{"id":2180513,"accession":"0000885590-12-000074","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000885590-12-000074","line_url":"/filing/0000885590-12-000074#line-7","is_derivative":false,"issuer_cik":"0000885590","issuer_name":"Valeant Pharmaceuticals International, Inc.","issuer_ticker":"VRX","issuer_name_source":null,"issuer_url":"/issuer/0000885590","owner_cik":"0001453140","owner_name":"DE SILVA RAJIV","owner_display_name":"DE SILVA RAJIV","owner_url":"/insider/0001453140","role":"Officer (Pres. & COO, Specialty Pharma)","role_mark":"O","role_mark_label":"Officer (Pres. & COO, Specialty Pharma)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Pres. & COO, Specialty Pharma","security_title":"Common Stock, no par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":121054.0,"shares_display":"121,054","price_per_share":54.047,"price_display":"54.05","price_state":"stated","total_value":6542605.538,"total_display":"6,542,605.54","total_whole":"6,542,606","shares_owned_after":364857.0,"shares_owned_after_display":"364,857","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-11-06","filed_date":"2012-11-08","scope":"insider"},{"id":2180510,"accession":"0000885590-12-000074","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000885590-12-000074","line_url":"/filing/0000885590-12-000074#line-6","is_derivative":false,"issuer_cik":"0000885590","issuer_name":"Valeant Pharmaceuticals International, Inc.","issuer_ticker":"VRX","issuer_name_source":null,"issuer_url":"/issuer/0000885590","owner_cik":"0001453140","owner_name":"DE SILVA RAJIV","owner_display_name":"DE SILVA RAJIV","owner_url":"/insider/0001453140","role":"Officer (Pres. & COO, Specialty Pharma)","role_mark":"O","role_mark_label":"Officer (Pres. & COO, Specialty Pharma)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Pres. & COO, Specialty Pharma","security_title":"Common Stock, no par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":99640.0,"shares_display":"99,640","price_per_share":54.78,"price_display":"54.78","price_state":"stated","total_value":5458279.2,"total_display":"5,458,279.20","total_whole":"5,458,279","shares_owned_after":265217.0,"shares_owned_after_display":"265,217","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-11-06","filed_date":"2012-11-08","scope":"insider"},{"id":2180506,"accession":"0000885590-12-000074","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000885590-12-000074","line_url":"/filing/0000885590-12-000074#line-5","is_derivative":false,"issuer_cik":"0000885590","issuer_name":"Valeant Pharmaceuticals International, Inc.","issuer_ticker":"VRX","issuer_name_source":null,"issuer_url":"/issuer/0000885590","owner_cik":"0001453140","owner_name":"DE SILVA RAJIV","owner_display_name":"DE SILVA RAJIV","owner_url":"/insider/0001453140","role":"Officer (Pres. & COO, Specialty Pharma)","role_mark":"O","role_mark_label":"Officer (Pres. & COO, Specialty Pharma)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Pres. & COO, Specialty Pharma","security_title":"Common Stock, no par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2.0,"shares_display":"2","price_per_share":0.0,"price_display":null,"price_state":"not-stated","total_value":0.0,"total_display":null,"total_whole":null,"shares_owned_after":265217.0,"shares_owned_after_display":"265,217","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-11-06","filed_date":"2012-11-08","scope":"insider"},{"id":2616934,"accession":"0001242616-12-000011","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001242616-12-000011","line_url":"/filing/0001242616-12-000011#line-1","is_derivative":false,"issuer_cik":"0000792977","issuer_name":"AMAG PHARMACEUTICALS INC.","issuer_ticker":"AMAG","issuer_name_source":null,"issuer_url":"/issuer/0000792977","owner_cik":"0001453140","owner_name":"DE SILVA RAJIV","owner_display_name":"DE SILVA RAJIV","owner_url":"/insider/0001453140","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":14822.0,"shares_display":"14,822","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":14822.0,"shares_owned_after_display":"14,822","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-05-24","filed_date":"2012-05-29","scope":"insider"},{"id":9068661,"accession":"0000885590-11-000059","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000885590-11-000059","line_url":"/filing/0000885590-11-000059#line-1","is_derivative":false,"issuer_cik":"0000885590","issuer_name":"Valeant Pharmaceuticals International, Inc.","issuer_ticker":"VRX","issuer_name_source":null,"issuer_url":"/issuer/0000885590","owner_cik":"0001453140","owner_name":"DE SILVA RAJIV","owner_display_name":"DE SILVA RAJIV","owner_url":"/insider/0001453140","role":"Officer (President & COO)","role_mark":"O","role_mark_label":"Officer (President & COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & COO","security_title":"Common Stock, no par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6180.0,"shares_display":"6,180","price_per_share":40.399,"price_display":"40.40","price_state":"stated","total_value":249665.82,"total_display":"249,665.82","total_whole":"249,666","shares_owned_after":241758.0,"shares_owned_after_display":"241,758","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-08-12","filed_date":"2011-08-16","scope":"insider"},{"id":7150453,"accession":"0000885590-10-000063","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000885590-10-000063","line_url":"/filing/0000885590-10-000063","is_derivative":false,"issuer_cik":"0000885590","issuer_name":"Valeant Pharmaceuticals International, Inc.","issuer_ticker":"VRX","issuer_name_source":null,"issuer_url":"/issuer/0000885590","owner_cik":"0001453140","owner_name":"DE SILVA RAJIV","owner_display_name":"DE SILVA RAJIV","owner_url":"/insider/0001453140","role":"Officer (President & COO Spec. Pharma)","role_mark":"O","role_mark_label":"Officer (President & COO Spec. Pharma)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & COO Spec. Pharma.","security_title":"Common Shares, no par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":219897.0,"shares_display":"219,897","price_per_share":27.0,"price_display":"27.00","price_state":"stated","total_value":5937219.0,"total_display":"5,937,219.00","total_whole":"5,937,219","shares_owned_after":291794.0,"shares_owned_after_display":"291,794","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-12-01","filed_date":"2010-12-02","scope":"insider","n_lines":2},{"id":7759165,"accession":"0001209499-10-000056","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209499-10-000056","line_url":"/filing/0001209499-10-000056","is_derivative":false,"issuer_cik":"0000930184","issuer_name":"VALEANT PHARMACEUTICALS INTERNATIONAL","issuer_ticker":"VRX","issuer_name_source":null,"issuer_url":"/issuer/0000930184","owner_cik":"0001453140","owner_name":"DE SILVA RAJIV","owner_display_name":"DE SILVA RAJIV","owner_url":"/insider/0001453140","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23000.0,"shares_display":"23,000","price_per_share":45.2421,"price_display":"45.24","price_state":"stated","total_value":1040568.3,"total_display":"1,040,568.30","total_whole":"1,040,568","shares_owned_after":96488.0,"shares_owned_after_display":"96,488","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-06-09","filed_date":"2010-06-11","scope":"insider","n_lines":2},{"id":5969056,"accession":"0001209499-09-000074","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209499-09-000074","line_url":"/filing/0001209499-09-000074#line-1","is_derivative":false,"issuer_cik":"0000930184","issuer_name":"VALEANT PHARMACEUTICALS INTERNATIONAL","issuer_ticker":"VRX","issuer_name_source":null,"issuer_url":"/issuer/0000930184","owner_cik":"0001453140","owner_name":"DE SILVA RAJIV","owner_display_name":"DE SILVA RAJIV","owner_url":"/insider/0001453140","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9007.0,"shares_display":"9,007","price_per_share":24.98,"price_display":"24.98","price_state":"stated","total_value":224994.86,"total_display":"224,994.86","total_whole":"224,995","shares_owned_after":98631.0,"shares_owned_after_display":"98,631","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-08-24","filed_date":"2009-08-25","scope":"insider"},{"id":5906694,"accession":"0001209500-09-000035","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209500-09-000035","line_url":"/filing/0001209500-09-000035#line-1","is_derivative":false,"issuer_cik":"0000930184","issuer_name":"VALEANT PHARMACEUTICALS INTERNATIONAL","issuer_ticker":"VRX","issuer_name_source":null,"issuer_url":"/issuer/0000930184","owner_cik":"0001453140","owner_name":"DE SILVA RAJIV","owner_display_name":"DE SILVA RAJIV","owner_url":"/insider/0001453140","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":11595.0,"shares_display":"11,595","price_per_share":17.2751,"price_display":"17.28","price_state":"stated","total_value":200304.7845,"total_display":"200,304.78","total_whole":"200,305","shares_owned_after":78029.0,"shares_owned_after_display":"78,029","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-02-27","filed_date":"2009-03-03","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":15,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":7,"open_market":true},{"code":"S","label":"Open-market sale","n":8,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":15},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001409269","name":"Venus Concept Inc.","url":"/issuer/0001409269","role":"Officer (Officer)","n_filings":1,"first_seen":"2022-11-22","last_seen":"2022-11-22"},{"type":"issuer","type_label":"ISSUER","cik":"0001593034","name":"Endo International plc","url":"/issuer/0001593034","role":"Director, Officer (President & CEO)","n_filings":2,"first_seen":"2015-11-12","last_seen":"2016-03-07"},{"type":"issuer","type_label":"ISSUER","cik":"0000885590","name":"Valeant Pharmaceuticals International, Inc.","url":"/issuer/0000885590","role":"Officer (Pres & COO, Specialty Pharm)","n_filings":4,"first_seen":"2010-12-02","last_seen":"2012-11-09"},{"type":"issuer","type_label":"ISSUER","cik":"0000792977","name":"AMAG PHARMACEUTICALS INC.","url":"/issuer/0000792977","role":"Director","n_filings":1,"first_seen":"2012-05-29","last_seen":"2012-05-29"},{"type":"issuer","type_label":"ISSUER","cik":"0000930184","name":"VALEANT PHARMACEUTICALS INTERNATIONAL","url":"/issuer/0000930184","role":"Officer (Chief Operating Officer)","n_filings":3,"first_seen":"2009-03-03","last_seen":"2010-06-11"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001453140","retrieved_at":"2026-08-22T23:26:46+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}